Treatment(s) already received-Surgery Posts on Medivizor
Navigation Menu

Treatment(s) already received-Surgery Posts on Medivizor

Can addition if oxaplatin to tegafur–uracil/leucovorin improve the outcome of patients with colorectal cancer?

Can addition if oxaplatin to tegafur–uracil/leucovorin improve the outcome of patients with colorectal cancer?

Posted by on Apr 30, 2021 in Colorectal cancer | 0 comments

In a nutshell The aim of this study was to evaluate the impact of adding oxaliplatin (Eloxatin) to the chemotherapy regimen tegafur uracil (UFT)/leucovorin (LV; folinic acid) for patients that had surgery for colorectal cancer (CRC). The study found that the addition of oxaliplatin to UFT/LV improved patient outcomes. Some background CRC can...

Read More

Can reducing chemotherapy duration from 6 to 3 months reduce side effects in patients with colorectal cancer and still be effective?

Can reducing chemotherapy duration from 6 to 3 months reduce side effects in patients with colorectal cancer and still be effective?

Posted by on Mar 6, 2021 in Colorectal cancer | 0 comments

In a nutshell This study investigated if reducing therapy duration could reduce side effects in patients but still be effective in patients with stage II colorectal cancer (CRC). This study showed that in certain patients a 3-month treatment duration can be considered.  Some background Patients with colorectal cancer (CRC) can be treated...

Read More

A shorter mFOLFOX/CAPOX treatment is effective and safe for patients with stage 2 colon cancer

A shorter mFOLFOX/CAPOX treatment is effective and safe for patients with stage 2 colon cancer

Posted by on Dec 26, 2020 in Colorectal cancer | 0 comments

In a nutshell This study compared 3 and 6 months of oxaliplatin (Eloxatin)-based chemotherapy in stage 2 colon cancer. Researchers suggested that the 3-month treatment might be a good and safer option for these patients. Some background Colorectal cancer is the third most common cancer diagnosed in both men and women in the US. Chemotherapy after...

Read More

Are intense follow-up programs beneficial for patients with colorectal cancer?

Posted by on Jan 10, 2020 in Colorectal cancer | 0 comments

In a nutshell This study reviewed the effect of follow-up programs on the survival of patients with colorectal cancer. Researchers suggested that intense follow-up programs do not improve the survival of these patients. Some background Colorectal cancer is a commonly diagnosed cancer in the US. Two in three patients will present with the possibly...

Read More

Surgery followed by chemotherapy improves the outcomes of patients with rectal cancer

Posted by on Oct 13, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness of surgery followed by chemotherapy without chemoradiotherapy (CRT) before surgery to treat rectal cancer. Researchers suggested that this treatment improves the outcomes of these patients.  Some background Colorectal cancer is the third most common cancer worldwide. The standard...

Read More

The role of chemotherapy after surgery in patients with rectal cancer with a complete response after pre-surgery treatment

Posted by on Jul 30, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the impact of chemotherapy after surgery (CAS) in patients with rectal cancer who had a complete response to chemotherapy before surgery. Researchers suggested that the routine use of CAS should not be recommended in these patients. Some background Colorectal cancer is one of the most common cancer...

Read More

Looking for participants with metastatic colorectal cancer to try a new treatment combination

Posted by on Mar 26, 2019 in Colorectal cancer | 0 comments

In a nutshell This trial is comparing the effectiveness and toxicity of ABT-165 or bevacizumab (Avastin) plus FOLFIRI (irinotecan, leucovorin, fluorouracil) chemotherapy in patients with metastatic (spread to other parts of the body) colorectal cancer. The main outcome to be measured will be tumor response and survival without cancer...

Read More

Searching for patients to test a new treatment for unresponsive multiple myeloma.

Posted by on Feb 9, 2019 in Multiple Myeloma | 0 comments

In a nutshell This trial is comparing the effectiveness of a new therapy, bb2121, to commonly used combinations of drugs for relapsing/refractory (unresponsive) multiple myeloma (RRMM). The main outcome to be measured is the time from the start of treatment until cancer worsens. The details Many patients are cured with standard treatments, such as...

Read More

Does chemotherapy after surgery improve survival in older patients with colon cancer?

Posted by on Sep 13, 2018 in Colorectal cancer | 0 comments

In a nutshell This study investigated the use of chemotherapy after surgery in elderly patients with stage 2 and 3 colon cancer. Researchers suggested that chemotherapy after surgery improves outcomes in patients with stage 3 colon cancer. Some background Life expectancy in the Western countries has increased. Colorectal cancer is diagnosed most...

Read More

Oxaliplatin based treatments as adjuvant chemotherapy treatment in colon cancer patients

Posted by on Jul 14, 2018 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness of a 3-month oxaliplatin-based chemotherapy treatment after surgery in patients with stage 3 colon cancer. Researchers suggested 6-months of treatment is associated with better outcomes. Some background The current standard treatment for stage 3 colon cancer patients is surgery followed by...

Read More